Supplement-Strategie: Monoprodukt oder All-in-One?

episode

Previously titled “#64 Supplement-Strategie: Monoprodukt oder All-in-One?” — renamed by the publisher on Aug 4, 2026

Beyond Lifespan - 2 Ärzte über Longevity & Biohacking not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

Board of County Supervisors - Joint Meeting with the School Board - Sep 23, 2026 2h 59m · 25 Sep 2026 · Prince William County Board of Supervisors

The Ezra Klein Show: Jensen Huang Thinks A.I. Alarmism Has Gone Too Far 1h 50m · 25 Sep 2026 · Hard Fork

Falling Oil Prices Offer Relief to Global Markets 3 min · 25 Sep 2026 · WSJ Minute Briefing

NPR News: 09-25-2026 6AM EDT 5 min · 25 Sep 2026 · NPR News Now

Real Easy English: Talking about autumn 9 min · 25 Sep 2026 · Learning Easy English

Costco checks out strong 4 min · 25 Sep 2026 · Wall Street Breakfast

Report any issue

Source

Recorded22 May 2025

Publisherbeyondlifespan.podigee.io ↗

Handlerec:12235196

Show notes

Stehst du auch oft vor dem Supplement-Regal und fragst dich: Einzelwirkstoff oder doch lieber die Kombi-Pille? Wir bringen Licht ins Dunkel und erklären dir die Vor- und Nachteile von Mono- und Komplexpräparaten, damit du die beste Wahl für dich treffen kannst.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related